G

Grown Rogue International Inc
CNSX:GRIN

Watchlist Manager
Grown Rogue International Inc
CNSX:GRIN
Watchlist
Price: 0.56 CAD -5.08% Market Closed
Market Cap: 138.8m CAD

Relative Value

The Relative Value of one GRIN stock under the Base Case scenario is hidden CAD. Compared to the current market price of 0.56 CAD, Grown Rogue International Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GRIN Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
28
vs Industry
24
Median 3Y
2.2
Median 5Y
2.3
Industry
2.5
vs History
vs Industry
10
Median 3Y
-6.7
Median 5Y
-6.3
Industry
21.6
vs History
11
vs Industry
19
Median 3Y
10.2
Median 5Y
6.9
Industry
16.7
vs History
28
vs Industry
5
Median 3Y
11.3
Median 5Y
-2.2
Industry
24
vs History
25
vs Industry
6
Median 3Y
4.2
Median 5Y
3.1
Industry
2.2
vs History
26
vs Industry
23
Median 3Y
2.1
Median 5Y
2.8
Industry
2.7
vs History
36
vs Industry
20
Median 3Y
4
Median 5Y
6.6
Industry
5.3
vs History
1
vs Industry
9
Median 3Y
16.3
Median 5Y
14.5
Industry
12.9
vs History
vs Industry
8
Median 3Y
10.1
Median 5Y
6.1
Industry
16.3
vs History
9
vs Industry
19
Median 3Y
10.6
Median 5Y
6.3
Industry
15.2
vs History
9
vs Industry
16
Median 3Y
19.1
Median 5Y
8.6
Industry
17.7
vs History
52
vs Industry
22
Median 3Y
2.3
Median 5Y
2.6
Industry
1.9

Multiples Across Competitors

GRIN Competitors Multiples
Grown Rogue International Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Grown Rogue International Inc
CNSX:GRIN
127.3m CAD 3.6 -15.2 204.4 -303.8
US
Eli Lilly and Co
NYSE:LLY
721.7B USD 14.7 65 34.9 38.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
392.1B USD 4.3 17.3 13.2 17.3
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK 6.1 17.8 12.3 14.1
CH
Roche Holding AG
SIX:ROG
204.7B CHF 3.4 24.8 9.3 10.9
CH
Novartis AG
SIX:NOVN
180.6B CHF 4.2 17.5 10.3 13.8
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 3.9 27.6 130.5 196.8
US
Merck & Co Inc
NYSE:MRK
205.1B USD 3.2 11.8 8.7 10.6
IE
Endo International PLC
LSE:0Y5F
183.8B USD 79.3 -62.9 292.4 733.2
US
Pfizer Inc
NYSE:PFE
139.7B USD 2.2 17.7 7.6 10.7
P/E Multiple
Earnings Growth PEG
CA
G
Grown Rogue International Inc
CNSX:GRIN
Average P/E: 24.9
Negative Multiple: -15.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
65
49%
1.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
17.3
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
17.8
18%
1
CH
Roche Holding AG
SIX:ROG
24.8
32%
0.8
CH
Novartis AG
SIX:NOVN
17.5
17%
1
UK
AstraZeneca PLC
LSE:AZN
27.6
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.8
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -62.9 N/A N/A
US
Pfizer Inc
NYSE:PFE
17.7
30%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
G
Grown Rogue International Inc
CNSX:GRIN
Average EV/EBITDA: 415.5
204.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
34.9
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
13.2
7%
1.9
DK
Novo Nordisk A/S
CSE:NOVO B
12.3
13%
0.9
CH
Roche Holding AG
SIX:ROG
9.3
5%
1.9
CH
Novartis AG
SIX:NOVN
10.3
5%
2.1
UK
AstraZeneca PLC
LSE:AZN
130.5
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.7
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
292.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
2%
3.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
G
Grown Rogue International Inc
CNSX:GRIN
Average EV/EBIT: 1 874.8
Negative Multiple: -303.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.2
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
17.3
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
14.1
14%
1
CH
Roche Holding AG
SIX:ROG
10.9
6%
1.8
CH
Novartis AG
SIX:NOVN
13.8
10%
1.4
UK
AstraZeneca PLC
LSE:AZN
196.8
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.6
11%
1
IE
E
Endo International PLC
LSE:0Y5F
733.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.7
10%
1.1